Aro Biotherapeutics
Rebecca Rhodes is a Scientist III at Aro Biotherapeutics, specializing in bio-conjugation in the Chemistry Team. Prior to this role, Rebecca was a Scientist I at KELLY OCG providing services for Janssen Research and Development, LLC, where Rebecca worked as a Protein Scientist in the Small Molecule and Protein Scientist Division. Rebecca also has experience as a Graduate Student Researcher at Drexel University College of Medicine and as a Student Researcher at The George Washington University Columbian College of Arts & Sciences. Rebecca holds a Master of Science in Biochemistry from Drexel University and a Bachelor of Science in Chemistry and History from The George Washington University.
Aro Biotherapeutics
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.